Frederick W. Driscoll

Chief Financial Officer, GENELABS TECHNOLOGIES INC /CA.

Companies

Lite Strategy, Inc.Board member Feb 26, 2018 to now¹
Cellectar Biosciences, Inc.Board member Apr 18, 2017 to now²
Cue Biopharma, Inc.Board member Jun 27, 2018 to Jan 3, 2025³
Invivyd, Inc.Chief financial officer Oct 13, 2022 to Oct 13, 2022⁴
Renovacor, Inc.Chief financial officer Mar 28, 2022 to Mar 28, 2022⁵
Flexion TherapeuticsChief financial officer Feb 11, 2014 to Nov 19, 2021⁶
ImmunityBio, Inc.Board member Sep 20, 2017 to Aug 13, 2020⁷
Conformis IncChief financial officer Oct 28, 2019 to Oct 28, 2019⁸
Oncotelic Therapeutics, Inc.Board member Jan 6, 2014 to Jun 3, 2016⁹
NovavaxChief financial officer Aug 25, 2009 to Mar 6, 2013¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lite Strategy, Inc. LITS1,875 shares¹¹$2.2K at $1.20Jul 17, 2025
Flexion Therapeutics0 shares¹²Nov 19, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 19, 2021Returned to company 30,680 shares at $8.50 of Flexion Therapeutics¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLite Strategy, Inc., Board member
2
SEC EDGARCellectar Biosciences, Inc., Board member
3
SEC EDGARCue Biopharma, Inc., Board member
4
SEC EDGARInvivyd, Inc., Chief financial officer
5
SEC EDGARRenovacor, Inc., Chief financial officer
6
SEC EDGARFlexion Therapeutics, Chief financial officer
7
SEC EDGARImmunityBio, Inc., Board member
8
SEC EDGARConformis Inc, Chief financial officer
9
SEC EDGAROncotelic Therapeutics, Inc., Board member
10
SEC EDGARNovavax, Chief financial officer
11
SEC EDGARLite Strategy, Inc. shares after the filing of Jul 17, 2025
12
SEC EDGARFlexion Therapeutics shares after the filing of Nov 19, 2021